Ipsen Study Director [clinicaltrials_resource:5daff475ec8a1a7c38828aabbca1ffd3]
Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport® [clinicaltrials:NCT02353897]Quality of Life in Patients With Inoperable Malignant Bowel Obstruction [clinicaltrials:NCT02365584]Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly [clinicaltrials:NCT02396953]Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke [clinicaltrials:NCT02444494]Dysport in the Treatment of Glabellar Lines in Chinese Subjects [clinicaltrials:NCT02450526]Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice [clinicaltrials:NCT02454803]Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly [clinicaltrials:NCT02493517]Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines [clinicaltrials:NCT02493946]
overall contact [clinicaltrials_vocabulary:overall-contact]
Ipsen Study Director [clinicaltrials_resource:5daff475ec8a1a7c38828aabbca1ffd3]
Bio2RDF identifier
5daff475ec8a1a7c38828aabbca1ffd3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5daff475ec8a1a7c38828aabbca1ffd3
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
Clinical.trials@ipsen.com
last name [clinicaltrials_vocabulary:last-name]
Ipsen Study Director
Ipsen Study Director, M.D.
Jovita Balcatiene, M.D.
Mustafa Noor, M.D.
Paola Mazzanti, MD
Qiu Ju Yuan, M.D.
Robert Roczeń, M.D., PhD
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:5daff475ec8a1a7c38828aabbca1ffd3
title
Ipsen Study Director
@en
Robert Roczeń, M.D., PhD
@en
type
label
Ipsen Study Director [clinicaltrials_resource:5daff475ec8a1a7c38828aabbca1ffd3]
@en
Robert Roczeń, M.D., PhD [clinicaltrials_resource:5daff475ec8a1a7c38828aabbca1ffd3]
@en